Quantcast

Latest Metaplasia Stories

2013-10-02 13:09:58

Radiofrequency ablation (RFA) leads to remission for 91 percent of patients with dysplastic Barrett's esophagus, according to new figures published in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association. Dysplastic Barrett's esophagus is the most serious grade of the condition in which precancerous cells are detected in the esophagus. "In order to make appropriate informed decisions about the use of radiofrequency...

2013-02-12 17:09:19

A new study from researchers at the Hospital of the University of Pennsylvania reports that endoluminal (endoscopic) therapies, combining resection and ablation techniques, for patients with Barrett's esophagus and high-grade dysplasia or early mucosal cancer have a high success rate, with durable results and a low risk of complications. The researchers noted that endoscopic surveillance after successful eradication is required. The study appears in the February issue of GIE: Gastrointestinal...

2011-08-11 21:25:55

Radiofrequency ablation (RFA) is a safe and effective option for the treatment of dysplastic Barrett's esophagus that attains lasting response, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. Progression of disease, which can precede cancer, was rare in patients who underwent RFA treatment, and there was no procedure- or cancer-related mortality. "This study reports the longest duration of follow-up of patients undergoing...

2011-06-27 21:12:07

Scientists from Singapore and the US identify a novel mechanism for evolution of highly aggressive cancers Dr Frank McKeon, Senior Group Leader of the Stem Cell and Developmental Biology at A*STAR's Genome Institute of Singapore (GIS), and Principal Investigator Dr Wa Xian at A*STAR's Institute of Medical Biology (IMB), together with their counterparts from the Harvard Medical School, the Brigham and Women's Hospital in Boston, and the National University of Singapore, have made the...

2011-06-21 07:27:29

(Ivanhoe Newswire) -- Patients with Barrett's esophagus may have a lower risk of esophageal cancer than previously thought, according to this study. Barrett's esophagus is a precancerous condition, and patients who have it are often advised to have regular endoscopies to watch for signs of esophageal adenocarcinoma, the most common kind of esophageal cancer. However, how often Barrett's esophagus progresses to cancer has not been clear. In this study, Shivaram Bhat, B.Ch., MRCP, of Queens...

2011-06-17 01:50:22

Patients with Barrett's esophagus may have a lower risk of esophageal cancer than previously reported, according to a large, long-term study published online June 16 in the Journal of the National Cancer Institute. Barrett's esophagus is a premalignant condition, and patients who have it are often advised to have regular endoscopies to watch for signs of esophageal adenocarcinoma, the most common kind of esophageal cancer in many parts of the world. But how often Barrett's esophagus...

2011-04-25 16:02:11

A new study reports that multipolar electrocoagulation in combination with acid suppression is a safe and effective method to ablate nondysplastic Barrett's esophagus over the long term. No adenocarcinoma (cancer) or high-grade dysplasia of the esophagus developed in any of the study patients. This is the largest published series and longest follow-up of patients with nondysplastic Barrett's esophagus who underwent ablation therapy with multipolar electrocoagulation. The study appears in the...

2010-07-14 07:00:00

SUNNYVALE, Calif., July 14 /PRNewswire/ -- BARRX Medical, Inc. today announced the closing of a $15 million Series D financing, which was led by new investor Highland Capital Partners and joined by existing investors Delphi Ventures, Alloy Ventures, Frazier Healthcare Ventures, Sutter Hill Ventures, Greenspring Associates and others. BARRX Medical, Inc. develops endoscopic treatment solutions for treating precancerous lesions of the esophagus as well as other chronic gastrointestinal...

2010-06-28 07:00:00

SUNNYVALE, Calif., June 28 /PRNewswire/ -- BARRX Medical Inc., a world leader in products to treat pre-cancerous tissue in the esophagus, reported today that the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom has published new guidelines approving the use of radiofrequency ablation for the eradication of dysplastic Barrett's esophagus. Barrett's esophagus is a precancerous condition that affects over 6.6 million people around the world and is caused by...

2010-05-05 14:29:00

NEW ORLEANS, May 5 /PRNewswire/ -- Results from two major multi-center clinical trials presented at the Digestive Disease Week in New Orleans independently confirmed that the effects of endoscopic radiofrequency ablation (RFA) for eradicating a pre-cancerous condition of the esophagus called Barrett's esophagus are durable in the long-term. In a plenary scientific presentation titled "Endoscopic Radiofrequency Ablation for Barrett's Esophagus: Five-year Durability Outcomes from a...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related